The boardroom shake-up at Redwood AI has injected fresh uncertainty into a stock already reeling from a 69% plunge off its April high. Graydon Bensler resigned from the board of directors with immediate effect on Friday, sending the shares to a provisional low of C$2.90. The company offered no explanation for the abrupt exit, leaving investors to piece together the narrative from a flurry of strategic announcements that followed.
A technical bounce on Monday lifted the stock nearly 9% on the Canadian Securities Exchange to close at C$3.15, while Tradegate saw an even sharper 10% gain. Yet the recovery barely scratches the surface of the damage done since the all-time high above C$10 in April. Annualised volatility remains above 130%, underscoring the speculative nature of this artificial-intelligence play. The current market capitalisation stands at roughly C$106 million.
Behind the price swings, management is touting rapid progress on the core Reactosphere platform, an AI system for chemical synthesis. The training database has ballooned from 4 million to over 21 million chemical reactions. To protect that intellectual property, Redwood AI filed a US patent application in early June for a planning module designed to slash laboratory costs and material waste in pharmaceutical research by calculating the minimum data required for reliable AI models.
Should investors sell immediately? Or is it worth buying Redwood AI?
Parallel initiatives across Africa and in defence research suggest a company trying to broaden its appeal. Redwood AI has signed a non-binding memorandum of understanding with a university in Rwanda to develop an AI-driven pathogen surveillance system. The project would combine geospatial data and genomic sequencing to track outbreaks of infectious diseases such as Ebola. Market observers have greeted the plan with scepticism: the MoU carries no concrete budget or committed funding. More tangible is the C$240,000 grant from the Canadian research council for Project Q-SAFE, which focuses on classifying hazardous chemical risks for military applications.
The most transformative move remains the planned acquisition of Quantum.IQ, a post-quantum cybersecurity firm. Redwood AI intends to pay up to 14 million new shares for the deal. If the integration of encryption technology with the Reactosphere database succeeds, management envisions a novel artificial-intelligence infrastructure combining chemical synthesis and quantum-safe security.
For now, the gap between ambition and execution is wide. The Africa MoU is legally non-binding. The Quantum.IQ acquisition has not closed. And the resignation of a board member adds an extra layer of governance concern. To rebuild trust, Redwood AI will need to convert its letters of intent into firm contracts — and prove that a database of 21 million chemical reactions can translate into revenue.
Ad
Redwood AI Stock: Buy or Sell?! New Redwood AI Analysis from June 16 delivers the answer:
The latest Redwood AI figures speak for themselves: Urgent action needed for Redwood AI investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 16.
Redwood AI: Buy or sell? Read more here...










